Myocardial stress |
Congestive heart failure, hypertension with left ventricular hypertrophy, aortic valve disease, hypertrophic obstructive cardiomyopathy with significant left ventricular hypertrophy, strenuous exercise, pulmonary embolism, emphysema and asthma |
Direct myocardial damage |
Cardiac contusion, direct current cardioversion, ablation and toxins (adriamycin, 5-fluorouracil and transtuzumab) |
Demand ischemia |
Sepsis, systemic inflammatory response syndrome, burn, hypotension, hypovolemia, left ventricular hypertrophy, sympathomimetic agents and supraventricular tachycardia |
Inflammation |
Myocarditis, pericarditis, Kawasaki disease and parvovirus B19 infection |
Infiltrative diseases |
Amyloidosis, hemochromatosis, sarcoidosis and scleroderma |
Immunological (autoantibodies, cytokines) causes |
Cardiac transplantation, systemic lupus erythematosus, burn and sepsis |
Unknown mechanism |
Chronic renal insufficiency, neurological diseases (cerebrovascular accident, subarachnoid bleed) |